The receptor tyrosine kinase MET and its ligand hepatocyte growth factor are strongly expressed in primary chordoma samples, and chordoma cell lines, particularly of sacral origin, are sensitive to MET inhibition (35). The gene discussed is MET; the disease is chordoma.